🔎 Trials Near Me

Hem › Lungcancer › Alabama

Kliniska studier för Lungcancer i Alabama

16 studier för Lungcancer söker deltagare vid platser i Alabama.

Städer i Alabama

Officiell studietext (engelska)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • Alabama Oncology, Birmingham
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06881784

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  • Clearview Cancer Institute (Crestwood), Huntsville
  • Clearview Cancer Institute, Huntsville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07489066

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • University of Alabama at Birmingham, Birmingham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07154290

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • University of Alabama at Birmingham, Birmingham
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology, Birmingham
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06712316

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • University of Alabama Birmingham, Birmingham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 10 sep. 2026 · NCT06293898

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Clearview Cancer Institute, Huntsville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  • O'Neal Comprehensive Cancer Center at UAB, Birmingham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06343402

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • University of Alabama at Birmingham Cancer Center, Birmingham
  • The Kirklin Clinic at Acton Road, Birmingham
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • och 3 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • Thomas Hospital, Fairhope
  • Mobile Infirmary Medical Center, Mobile
  • och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 3 juni 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

  • Southern Cancer Center, PC, Daphne
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 18 maj 2026 · NCT05885698

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • Thomas Hospital, Fairhope
  • Mobile Infirmary Medical Center, Mobile
  • och 1 fler
RekryterarFas 2
18 Minutes · Alla kön · Uppdaterad 5 maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • Thomas Hospital, Fairhope
  • Mobile Infirmary Medical Center, Mobile
  • och 1 fler
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 maj 2026 · NCT06616584

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • University of Alabama at Birmingham, Birmingham
  • University of South Alabama, Mobile
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 30 apr. 2026 · NCT05297734

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Birmingham
  • Massive Bio SYNERGY-AI site, Mobile
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

  • XCancer Research Network/Dothan Hematology & Oncology, Dothan
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 okt. 2025 · NCT06228326

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.